跳转至内容
Merck
CN

171610

Sigma-Aldrich

抗淀粉样蛋白前体蛋白,C-末端(751-770)兔pAb

liquid, Calbiochem®

别名:

Anti-0443, Anti-APP-CT20

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
12352203
NACRES:
NA.43
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

生物来源

rabbit

质量水平

抗体形式

serum

抗体产品类型

primary antibodies

克隆

polyclonal

表单

liquid

种属反应性

human

制造商/商品名称

Calbiochem®

储存条件

OK to freeze

dilution

(Immunoblotting (1:5000-1:20,000)
Immunofluorescence (1:1000)
Immunohistochemistry (1:1000)
Immunoprecipitation (1:1000))

同位素/亚型

IgG

运输

ambient

储存温度

−20°C

靶向翻译后修饰

unmodified

一般描述

兔多克隆抗体以未稀释的血清形式提供。识别全长APP和C端可溶性产物CTFγ(~6 kDa)、CTFα(~9 kDa)和CTFβ(~11 kDa)。
兔多克隆抗淀粉样蛋白前体蛋白C末端(751-770)可识别全长APP和C末端可溶性产物CTFα,β和γ。经验证可用于WB、IF、IHC和IP。
识别全长APP和C端可溶性产物CTFγ(~6 kDa)、CTFα(~9 kDa)和CTFβ(~11 kDa)。
  • 抗体靶基因符号:APP
  • 靶标异名:AAA,AD1,Adap,AL024401,淀粉样蛋白前体,淀粉样蛋白糖蛋白,APP异构体1,APPI,appican,CTFgamma,CVAP,E030013M08RIK,Nexin II,P3,PN2,PreA4,蛋白酶 NEXIN2
  • Entrez基因名称:淀粉样β(A4)前体蛋白
  • Hu Entrez ID:351(相关抗体:PC729, PC152,PC151, PC150, PC149, NE1012,171609, 171608, 171607, 171606, 171605, 171604, 171603, 171598, 171537)
  • Mu Entrez ID: 11820
  • 大鼠Entrez ID:54226
  • 免疫原

    合成肽[(C)KMQQNGYENPTYKFFEQMQN],对应于人前体蛋白(APP)的751-770位氨基酸,与KLH偶联

    应用

    免疫印迹(1:5000-1:20,000)

    免疫荧光(1:1000)

    免疫组织化学(1:1000)

    免疫沉淀(1:1000)

    制备说明

    初次融化后,等分并冷冻(-20°C)。

    其他说明

    Pinnix, I., et al. 2001.J. Biol. Chem.276, 481.
    合适的工作稀释度由与测定条件相关的变量决定。

    法律信息

    采购本材料仅供研究使用。在将0433抗体或任何衍生物用于临床诊断或治疗目的之前,请用户向Mayo索取许可证。有关许可信息,请联系:Mayo Medical Ventures,技术商业化办公室(507)284-8878,200 First Street SW,Rochester,MN 55905-001。
    CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

    免责声明

    毒性:标准处理(A)

    未找到合适的产品?  

    试试我们的产品选型工具.

    储存分类代码

    10 - Combustible liquids

    WGK

    WGK 1

    闪点(°F)

    Not applicable

    闪点(°C)

    Not applicable


    分析证书(COA)

    输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Dario Tejera et al.
    The EMBO journal, 38(17), e101064-e101064 (2019-07-31)
    Alzheimer's disease is the most prevalent type of dementia and is caused by the deposition of extracellular amyloid-beta and abnormal tau phosphorylation. Neuroinflammation has emerged as an additional pathological component. Microglia, representing the brain's major innate immune cells, play an
    Vincent J Mecozzi et al.
    Nature chemical biology, 10(6), 443-449 (2014-04-22)
    Retromer is a multiprotein complex that trafficks cargo out of endosomes. The neuronal retromer traffics the amyloid-precursor protein (APP) away from endosomes, a site where APP is cleaved into pathogenic fragments in Alzheimer's disease. Here we determined whether pharmacological chaperones
    Yang Xiang et al.
    Acta neuropathologica, 130(4), 487-499 (2015-09-14)
    Amyloid-beta (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). The physiological capacity of peripheral tissues and organs in clearing brain-derived Aβ and its therapeutic potential for AD remains largely unknown. Here, we measured blood Aβ levels
    Jenna C Carroll et al.
    Brain research, 1366, 233-245 (2010-10-12)
    The risk of Alzheimer's disease (AD) is higher in women than in men, a sex difference that likely results from the effects of sex steroid hormones. To investigate this relationship, we first compared progression of β-amyloid (Aβ) pathology in male
    Giselle P Lim et al.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 25(12), 3032-3040 (2005-03-25)
    Epidemiological studies suggest that increased intake of the omega-3 (n-3) polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) is associated with reduced risk of Alzheimer's disease (AD). DHA levels are lower in serum and brains of AD patients, which could result

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持